Greco Michael V. 4
4 · Veradermics, Inc · Filed Feb 5, 2026
Research Summary
AI-generated summary of this filing
Veradermics (MANE) GC Michael Greco Receives 144,401-Share Award
What Happened
- Michael V. Greco, General Counsel of Veradermics, was granted a derivative equity award (transaction code A) covering 144,401 shares on February 3, 2026. The award shows an acquisition price of $0.00 per share (no cash paid at grant) — this is a compensation grant, not an open-market purchase or sale.
Key Details
- Transaction date: February 3, 2026; Form 4 filed February 5, 2026 (appears timely).
- Transaction type: A = Award/Grant (derivative equity instrument).
- Shares/amount: 144,401 shares underlying the award.
- Price: $0.00 per share at grant (no immediate cash outlay).
- Vesting (per footnote F1): 25% vests on Feb 3, 2027 (one-year cliff), then remaining shares vest in equal monthly installments over the next 36 months, subject to continued service.
- Shares owned after transaction: Not specified in the filing.
- No indication in the filing of a 10b5-1 plan, tax-withholding share surrender, or immediate sale of shares.
Context
- This is a standard executive compensation grant. Because it vests over time and requires continued service, any financial benefit to the insider depends on future vesting and any later exercise/sale; there was no immediate purchase or sale of stock reported.
Insider Transaction Report
Form 4
Veradermics, IncMANE
Greco Michael V.
General Counsel
Transactions
- Award
Stock Option (Right to Buy)
[F1]2026-02-03+144,401→ 144,401 totalExercise: $17.00Exp: 2036-02-03→ Common Stock (144,401 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the underlying shares of the Issuer's common stock, par value $0.00001 per share, on February 3, 2027, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal monthly installments over 36 months thereafter, subject to continued service.
Signature
/s/ Michael Greco|2026-02-05